trending Market Intelligence /marketintelligence/en/news-insights/trending/dADL0kM0tXNt_uuFhgydaQ2 content esgSubNav
In This List

Immune Pharmaceuticals appoints COO

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Immune Pharmaceuticals appoints COO

Immune Pharmaceuticals Inc. appointed Tony Fiorino to the joint position of chief medical officer and COO of the company.

Fiorino previously served as president and CEO of Triumvira Immunologics, an immuno-oncology company developing an engineered T cell platform.